Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities

Nicholas W Bateman^#^{1

2

3}, Tamara Abulez^{4

5}, Anthony R Soltis⁶, Andrew McPherson⁷, Seongmin Choi⁷, Dale W Garsed^{8

9}, Ahwan Pandey⁸, Chunqiao Tian^{4

5}, Brian L Hood^{4

5}, Kelly A Conrads^{4

5}, Pang-Ning Teng^{4

5}, Julie Oliver^{4

5}, Glenn Gist^{4

5}, Dave Mitchell^{4

5}, Tracy J Litzi^{4

5}, Christopher M Tarney⁴, Barbara A Crothers¹⁰, Paulette Mhawech-Fauceglia¹¹, Clifton L Dalgard⁶, Matthew D Wilkerson⁶, Mariaelena Pierobon¹², Emanuel F Petricoin¹², Chunhua Yan¹³, Daoud Meerzaman¹³, Clara Bodelon¹⁴, Nicolas Wentzensen¹⁴, Jerry S H Lee¹⁵; APOLLO Research Network; David G Huntsman¹⁶, Sohrab Shah⁷, Craig D Shriver¹⁷, Neil T Phippen⁴, Kathleen M Darcy^{4

5

17}, David D L Bowtell^{8

9}, Thomas P Conrads^#^{18

19

20}, G Larry Maxwell^#^{21

22

23}

Collaborators, Affiliations

Affiliations

¹ Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. batemann@whirc.org.
² The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Bethesda, MD, USA. batemann@whirc.org.
³ The John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA. batemann@whirc.org.
⁴ Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
⁵ The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Bethesda, MD, USA.
⁶ The American Genome Center, Collaborative Health Initiative Research Program, Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
⁷ Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, Manhattan, NY, USA.
⁸ Peter MacCallum Cancer Centre, Parkville, Melbourne, Victoria, Australia.
⁹ Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
¹⁰ The Joint Pathology Center, Defense Health Agency, National Capital Region Medical Directorate, Silver Spring, MD, USA.
¹¹ Department of Anatomic Pathology, Division of Gynecologic Pathology, University of Southern California, Los Angeles, CA, USA.
¹² Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
¹³ Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, USA.
¹⁴ Division of Cancer Epidemiology and Genetics National Cancer Institute, Rockville, MD, USA.
¹⁵ Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, CA, USA.
¹⁶ Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
¹⁷ The John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.
¹⁸ Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. conrads@whirc.org.
¹⁹ The John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA. conrads@whirc.org.
²⁰ Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA, USA. conrads@whirc.org.
²¹ Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. george.maxwell@inova.org.
²² The John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA. george.maxwell@inova.org.
²³ Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA, USA. george.maxwell@inova.org.

^# Contributed equally.

PMID: 38710993
PMCID: PMC11074115
DOI: 10.1038/s41698-024-00588-9

Published Erratum

Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities

Nicholas W Bateman et al. NPJ Precis Oncol. 2024.

. 2024 May 6;8(1):97.

doi: 10.1038/s41698-024-00588-9.

Authors

Affiliations

¹ Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. batemann@whirc.org.
² The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Bethesda, MD, USA. batemann@whirc.org.
³ The John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA. batemann@whirc.org.
⁴ Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
⁵ The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Bethesda, MD, USA.
⁶ The American Genome Center, Collaborative Health Initiative Research Program, Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
⁷ Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, Manhattan, NY, USA.
⁸ Peter MacCallum Cancer Centre, Parkville, Melbourne, Victoria, Australia.
⁹ Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
¹⁰ The Joint Pathology Center, Defense Health Agency, National Capital Region Medical Directorate, Silver Spring, MD, USA.
¹¹ Department of Anatomic Pathology, Division of Gynecologic Pathology, University of Southern California, Los Angeles, CA, USA.
¹² Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
¹³ Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, USA.
¹⁴ Division of Cancer Epidemiology and Genetics National Cancer Institute, Rockville, MD, USA.
¹⁵ Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, CA, USA.
¹⁶ Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
¹⁷ The John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.
¹⁸ Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. conrads@whirc.org.
¹⁹ The John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA. conrads@whirc.org.
²⁰ Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA, USA. conrads@whirc.org.
²¹ Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. george.maxwell@inova.org.
²² The John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA. george.maxwell@inova.org.
²³ Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA, USA. george.maxwell@inova.org.

^# Contributed equally.

PMID: 38710993
PMCID: PMC11074115
DOI: 10.1038/s41698-024-00588-9

No abstract available

PubMed Disclaimer

Erratum for

Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.
Bateman NW, Abulez T, Soltis AR, McPherson A, Choi S, Garsed DW, Pandey A, Tian C, Hood BL, Conrads KA, Teng PN, Oliver J, Gist G, Mitchell D, Litzi TJ, Tarney CM, Crothers BA, Mhawech-Fauceglia P, Dalgard CL, Wilkerson MD, Pierobon M, Petricoin EF, Yan C, Meerzaman D, Bodelon C, Wentzensen N, Lee JSH; APOLLO Research Network; Huntsman DG, Shah S, Shriver CD, Phippen NT, Darcy KM, Bowtell DDL, Conrads TP, Maxwell GL. Bateman NW, et al. NPJ Precis Oncol. 2024 Mar 13;8(1):68. doi: 10.1038/s41698-024-00519-8. NPJ Precis Oncol. 2024. PMID: 38480868 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities

Collaborators

Affiliations

Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities

Authors

Collaborators

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources